home / stock / wald / wald news


WALD News and Press, Waldencast Acquisition Corp. From 01/28/26

Stock Information

Company Name: Waldencast Acquisition Corp.
Stock Symbol: WALD
Market: NASDAQ
Website: waldencast.com

Menu

WALD WALD Quote WALD Short WALD News WALD Articles WALD Message Board
Get WALD Alerts

News, Short Squeeze, Breakout and More Instantly...

WALD - Obagi Medical and Next Health Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ(TM)

NEW YORK and LOS ANGELES, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), today announced Next Health as a key partne...

WALD - UPDATE - Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ(TM)

NEW YORK and SACRAMENTO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), today announced that it has partnere...

WALD - Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ(TM)

NEW YORK and SACRAMENTO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), today announced that it has partnere...

WALD - CORRECTION - Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ(TM)

In a release issued under the same headline earlier today by Waldencast plc (NASDAQ: WALD), please note that the quote by Michael Pennington in paragraph 3 was incorrect. The corrected release follows: NEW YORK and DALLAS, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in ...

WALD - Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ(TM)

NEW YORK and DALLAS, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), today announced Platinum Dermatology Partners ...

WALD - Obagi Medical Unveils ALOHA Program to Launch Obagi® saypha® MagIQ(TM) - Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler

NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), today announced the launch of the ALOHA (Aesthetic Leadersh...

WALD - Buy Recommendation Issued On WALD By Alden

2025-11-25 07:15:11 ET Alden analyst issues BUY recommendation for WALD on November 25, 2025 12:00PM ET. The previous analyst recommendation was Buy. WALD was trading at $2.88 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analys...

WALD - Waldencast reports Q2 results; updates FY outlook

2025-11-24 07:14:27 ET More on Waldencast Waldencast: Fairly Valued With Ulta Lift Already Reflected, Saypha Deal Adds Optionality Seeking Alpha’s Quant Rating on Waldencast Historical earnings data for Waldencast Financial information for Waldencast ...

WALD - Waldencast Announces Q2 2025 Results and Provides Q3 2025 Trading Update

Transformation efforts drive performance improvements at Obagi Medical with accelerating revenue Contrasted performance for Milk Makeup with Q2 2025 net revenue growth driven by U.S. channel expansion and sell-out acceleration but softer performance in Q3 2025 in international markets Com...

WALD - Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting

NEW YORK, Nov. 16, 2025 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD), today announced new data shared at the recent American Society for Dermatologic Surgery (ASDS) Annual Meeting, which to...

Previous 10 Next 10